Autio Matias, Brück Oscar, Pollari Marjukka, Karjalainen-Lindsberg Marja-Liisa, Beiske Klaus, Jørgensen Judit Mészaros, Holte Harald, Pellinen Teijo, Leivonen Suvi-Katri, Leppä Sirpa
Research Programs Unit, Applied Tumor Genomics, University of Helsinki, Helsinki, Finland; Department of Oncology, University of Helsinki and Helsinki University Hospital Comprehensive Cancer Center, Helsinki, Finland; iCAN Digital Precision Medicine Flagship, Helsinki.
Hematoscope Lab, Comprehensive Cancer Center and Center of Diagnostics, Helsinki University Hospital, Helsinki, Finland; Department of Oncology, University of Helsinki, Helsinki.
Haematologica. 2025 Jun 1;110(6):1339-1350. doi: 10.3324/haematol.2024.286267. Epub 2024 Dec 12.
The tumor microenvironments (TME) of diffuse large B-cell lymphoma (DLBCL) subgroups have remained poorly characterized. Here, we dissected the composition and spatial organization of the TME in germinal center B-cell (GCB), activated B-cell (ABC), and testicular (T-) DLBCL using gene expression profiling and multiplex immunohistochemistry. We found that high proportions of M2-like tumor-associated macrophages (TAM) and cytotoxic tumor-infiltrating T cells (TIL) were characteristic of ABC DLBCL TME. Furthermore, high CD8+ TIL content translated to favorable outcomes. In contrast, GCB DLBCL TME was enriched in CD4+ TIL, regulatory TIL, and a higher M1-like: M2-like TAM ratio, and high proportions of TAM and Granzyme B+ cells associated with worse survival. TIL and TAM interacted more frequently with M2-like TAM and cytotoxic TIL in the ABC DLBCL in contrast to GCB subtype, where the interactions were more abundant with other TIL and CD4+ TIL. In T-DLBCL, TME resembled that of ABC DLBCL with a higher proportion of M2-like TAM and cytotoxic cells, except that checkpoint-positive TIL were less prominent compared to DLBCL NOS. Cytotoxic TIL also interacted more with TIL and TAM. A large number of CD163+ TAM interactions with distinct TIL translated to unfavorable survival both in GCB DLBCL and T-DLBCL, whereas a high number of interactions between TIL and TAM, CD4+ TIL and TAM, and CD4+ TIL and other TIL were associated with favorable outcomes only in T-DLBCL. Together, our data demonstrate biologically and clinically relevant differences in the composition of and cellular interactions in the TME between various DLBCL entities.
弥漫性大B细胞淋巴瘤(DLBCL)亚组的肿瘤微环境(TME)特征仍不明确。在此,我们利用基因表达谱分析和多重免疫组化剖析了生发中心B细胞(GCB)、活化B细胞(ABC)和睾丸(T-)DLBCL中TME的组成和空间组织。我们发现,高比例的M2样肿瘤相关巨噬细胞(TAM)和细胞毒性肿瘤浸润T细胞(TIL)是ABC DLBCL TME的特征。此外,高CD8+ TIL含量预示着良好的预后。相比之下,GCB DLBCL TME富含CD4+ TIL、调节性TIL,且M1样:M2样TAM比例更高,高比例的TAM和颗粒酶B+细胞与较差的生存率相关。与GCB亚型相比,ABC DLBCL中TIL和TAM与M2样TAM和细胞毒性TIL的相互作用更频繁,而在GCB亚型中,与其他TIL和CD4+ TIL的相互作用更为丰富。在T-DLBCL中,TME与ABC DLBCL相似,M2样TAM和细胞毒性细胞比例更高,但与DLBCL非特指型(NOS)相比,检查点阳性TIL不那么突出。细胞毒性TIL也与TIL和TAM的相互作用更多。在GCB DLBCL和T-DLBCL中,大量CD163+ TAM与不同TIL的相互作用均预示着不良生存,而仅在T-DLBCL中,TIL与TAM、CD4+ TIL与TAM以及CD4+ TIL与其他TIL之间的大量相互作用与良好预后相关。总之,我们的数据表明,不同DLBCL实体的TME在组成和细胞相互作用方面存在生物学和临床相关差异。